Literature DB >> 31666356

Audiogenic Seizures in the Fmr1 Knock-Out Mouse Are Induced by Fmr1 Deletion in Subcortical, VGlut2-Expressing Excitatory Neurons and Require Deletion in the Inferior Colliculus.

Darya Gonzalez1, Madison Tomasek1, Seth Hays1, Vinay Sridhar1, Simon Ammanuel1, Chia-Wei Chang1, Karen Pawlowski2, Kimberly M Huber3, Jay R Gibson3.   

Abstract

Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and the leading monogenetic cause of autism. One symptom of FXS and autism is sensory hypersensitivity (also called sensory over-responsivity). Perhaps related to this, the audiogenic seizure (AGS) is arguably the most robust behavioral phenotype in the FXS mouse model-the Fmr1 knock-out (KO) mouse. Therefore, the AGS may be considered a mouse model of sensory hypersensitivity. Hyperactive circuits are hypothesized to underlie dysfunction in a number of brain regions in patients with FXS and Fmr1 KO mice, and the AGS may be a result of this. But the specific cell types and brain regions underlying AGSs in the Fmr1 KO are unknown. We used conditional deletion or expression of Fmr1 in different cell populations to determine whether Fmr1 deletion in those cells was sufficient or necessary, respectively, for the AGS phenotype in males. Our data indicate that Fmr1 deletion in glutamatergic neurons that express vesicular glutamate transporter 2 (VGlut2) and are located in subcortical brain regions is sufficient and necessary to cause AGSs. Furthermore, the deletion of Fmr1 in glutamatergic neurons of the inferior colliculus is necessary for AGSs. When we demonstrate necessity, we show that Fmr1 expression in either the larger population of VGlut2-expressing glutamatergic neurons or the smaller population of inferior collicular glutamatergic neurons-in an otherwise Fmr1 KO mouse-eliminates AGSs. Therefore, targeting these neuronal populations in FXS and autism may be part of a therapeutic strategy to alleviate sensory hypersensitivity.SIGNIFICANCE STATEMENT Sensory hypersensitivity in fragile X syndrome (FXS) and autism patients significantly interferes with quality of life. Audiogenic seizures (AGSs) are arguably the most robust behavioral phenotype in the FXS mouse model-the Fmr1 knockout-and may be considered a model of sensory hypersensitivity in FXS. We provide the clearest and most precise genetic evidence to date for the cell types and brain regions involved in causing AGSs in the Fmr1 knockout and, more broadly, for any mouse mutant. The expression of Fmr1 in these same cell types in an otherwise Fmr1 knockout eliminates AGSs indicating possible cellular targets for alleviating sensory hypersensitivity in FXS and other forms of autism.
Copyright © 2019 the authors.

Entities:  

Keywords:  Fmr1; auditory; fragile X; hypersensitivity; mouse; seizure

Mesh:

Substances:

Year:  2019        PMID: 31666356      PMCID: PMC6891051          DOI: 10.1523/JNEUROSCI.0886-19.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  130 in total

1.  Expression of glutamate and inhibitory amino acid vesicular transporters in the rodent auditory brainstem.

Authors:  Tetsufumi Ito; Deborah C Bishop; Douglas L Oliver
Journal:  J Comp Neurol       Date:  2011-02-01       Impact factor: 3.215

2.  Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.

Authors:  Jonathan W Lovelace; Teresa H Wen; Sarah Reinhard; Mike S Hsu; Harpreet Sidhu; Iryna M Ethell; Devin K Binder; Khaleel A Razak
Journal:  Neurobiol Dis       Date:  2016-02-02       Impact factor: 5.996

3.  Postsynaptic FMRP promotes the pruning of cell-to-cell connections among pyramidal neurons in the L5A neocortical network.

Authors:  Ankur B Patel; Kristofer W Loerwald; Kimberly M Huber; Jay R Gibson
Journal:  J Neurosci       Date:  2014-02-26       Impact factor: 6.167

Review 4.  Role of GABA abnormalities in the inferior colliculus pathophysiology - audiogenic seizures.

Authors:  Carl L Faingold
Journal:  Hear Res       Date:  2002-06       Impact factor: 3.208

5.  Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486.

Authors:  Bridget M Dolan; Sergio G Duron; David A Campbell; Benedikt Vollrath; B S Shankaranarayana Rao; Hui-Yeon Ko; Gregory G Lin; Arvind Govindarajan; Se-Young Choi; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

6.  Hearing loss is an early consequence of Npc1 gene deletion in the mouse model of Niemann-Pick disease, type C.

Authors:  Kelly A King; Sandra Gordon-Salant; Karen S Pawlowski; Anna M Taylor; Andrew J Griffith; Ari Houser; Kiyoto Kurima; Christopher A Wassif; Charles G Wright; Forbes D Porter; Joyce J Repa; Carmen C Brewer
Journal:  J Assoc Res Otolaryngol       Date:  2014-05-17

7.  Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.

Authors:  Aubin Michalon; Michael Sidorov; Theresa M Ballard; Laurence Ozmen; Will Spooren; Joseph G Wettstein; Georg Jaeschke; Mark F Bear; Lothar Lindemann
Journal:  Neuron       Date:  2012-04-12       Impact factor: 17.173

8.  Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.

Authors:  Jennifer A Ronesi; Katie A Collins; Seth A Hays; Nien-Pei Tsai; Weirui Guo; Shari G Birnbaum; Jia-Hua Hu; Paul F Worley; Jay R Gibson; Kimberly M Huber
Journal:  Nat Neurosci       Date:  2012-01-22       Impact factor: 24.884

9.  Assembly of the auditory circuitry by a Hox genetic network in the mouse brainstem.

Authors:  Maria Di Bonito; Yuichi Narita; Bice Avallone; Luigi Sequino; Marta Mancuso; Gennaro Andolfi; Anna Maria Franzè; Luis Puelles; Filippo M Rijli; Michèle Studer
Journal:  PLoS Genet       Date:  2013-02-07       Impact factor: 5.917

10.  Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible.

Authors:  Anubhuti Goel; Daniel A Cantu; Janna Guilfoyle; Gunvant R Chaudhari; Aditi Newadkar; Barbara Todisco; Diego de Alba; Nazim Kourdougli; Lauren M Schmitt; Ernest Pedapati; Craig A Erickson; Carlos Portera-Cailliau
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

View more
  11 in total

1.  (S)-5-(2'-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder.

Authors:  Jessica L Armstrong; Austen B Casey; Tanishka S Saraf; Munmun Mukherjee; Raymond G Booth; Clinton E Canal
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

2.  Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome.

Authors:  Anna O Nguyen; Devin K Binder; Iryna M Ethell; Khaleel A Razak
Journal:  J Neurophysiol       Date:  2020-04-22       Impact factor: 2.714

3.  A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.

Authors:  Andrew J Holley; Aleya Shedd; Anna Boggs; Jonathan Lovelace; Craig Erickson; Christina Gross; Miranda Jankovic; Khaleel Razak; Kimberly Huber; Jay R Gibson
Journal:  Neurobiol Dis       Date:  2022-05-17       Impact factor: 7.046

4.  Spontaneous seizures in adult Fmr1 knockout mice: FVB.129P2-Pde6b+Tyrc-chFmr1tm1Cgr/J.

Authors:  Jessica L Armstrong; Tanishka S Saraf; Omkar Bhatavdekar; Clinton E Canal
Journal:  Epilepsy Res       Date:  2022-03-08       Impact factor: 2.991

Review 5.  Mechanisms underlying auditory processing deficits in Fragile X syndrome.

Authors:  Elizabeth A McCullagh; Sarah E Rotschafer; Benjamin D Auerbach; Achim Klug; Leonard K Kaczmarek; Karina S Cramer; Randy J Kulesza; Khaleel A Razak; Jonathan W Lovelace; Yong Lu; Ursula Koch; Yuan Wang
Journal:  FASEB J       Date:  2020-02-10       Impact factor: 5.191

Review 6.  Interneuron Dysfunction and Inhibitory Deficits in Autism and Fragile X Syndrome.

Authors:  Toshihiro Nomura
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

7.  Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice.

Authors:  Tanishka S Saraf; Daniel E Felsing; Jessica L Armstrong; Raymond G Booth; Clinton E Canal
Journal:  Epilepsy Res       Date:  2021-05-27       Impact factor: 2.991

8.  Dysregulation of GABAA Receptor-Mediated Neurotransmission during the Auditory Cortex Critical Period in the Fragile X Syndrome Mouse Model.

Authors:  Yeri J Song; Bo Xing; Aaron J Barbour; Chengwen Zhou; Frances E Jensen
Journal:  Cereb Cortex       Date:  2021-11-23       Impact factor: 4.861

Review 9.  The Inferior Colliculus in Alcoholism and Beyond.

Authors:  Tanuja Bordia; Natalie M Zahr
Journal:  Front Syst Neurosci       Date:  2020-12-11

10.  Hyperexcitability and Homeostasis in Fragile X Syndrome.

Authors:  Xiaopeng Liu; Vipendra Kumar; Nien-Pei Tsai; Benjamin D Auerbach
Journal:  Front Mol Neurosci       Date:  2022-01-06       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.